Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

14 Results

Guidelines and Advice

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Status: Archived
ID: 1-18

May 2012

Guidelines and Advice

The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast Cancer

Status: Archived
ID: 1-5

Sep 2012

Guidelines and Advice

The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer

Status: Archived
ID: 1-17

May 2012

Guidelines and Advice

The Use of Conformal Radiotherapy and the Selection of Radiation Dose in T1 or T2 Prostate Cancer

Status: Archived
ID: 3-11

Jan 2012

Guidelines and Advice

The Management of Dyspnea in Cancer Patients

Status: Archived
ID: 13-5

Apr 2012

Guidelines and Advice

The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma

Status: Archived
ID: 3-8-3

May 2012

Guidelines and Advice

The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer

Status: Archived
ID: 5-8

Apr 2012

Guidelines and Advice

The Role of Bisphosphonates in the Management of Skeletal Complications for Patients with Multiple Myeloma

Status: Archived
ID: 6-4

Oct 2012

Drug

teclistamab

Other Name(s): Tecvayli®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Jan 2025

Guidelines and Advice

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Status: Current
ID: MOTAC-7

Updated

Jan 2025

Drug

treosulfan

Other Name(s): Trecondyv®

Quick Link(s):

Jan 2025

Drug

tucatinib

Other Name(s): Tukysa™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Feb 2025

Pages